Symbol
ALGS on Nasdaq
Investment type
Equity / Voting Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned
175,509 shares
Security Ownership %
3.2%

Lawrence M. Blatt, Ph.D. ownership in Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS)

12 Mar 2025 - Lawrence M. Blatt, Ph.D. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 175,509 shares of Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS). This represents 3.2% ownership of the company. This is the first filing by Lawrence M. Blatt disclosing ownership of Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS).